/Investor DB

Samsara BioCapital — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Principia Biopharmaprincipiabio.comJul 2015SEC filingmedium confidence

BiotechSouth San Francisco, US

MARTIN BABLER(Executive Officer, Director)in

BoardPETER THOMPSON(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)

Board seatSrinivas AkkarajuMichael Dybbs· per SEC Form D · $50M raise · filed Sep 2018

Co-investorsAccess BiotechnologyMission BiocapitalSofinnova VenturesSR One Capital ManagementMission Bay CapitalNew Leaf Venture Partners+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.